• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症对直肠癌新辅助放化疗后病理完全缓解的影响。

The impact of sarcopenia on pathologic complete response following neoadjuvant chemoradiation in rectal cancer.

机构信息

Department of Gastrointestinal Surgery, Kosuyolu Research and Education Hospital, University of Health Sciences, 34865, Istanbul, Turkey.

Department of Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

Langenbecks Arch Surg. 2020 Dec;405(8):1131-1138. doi: 10.1007/s00423-020-01983-z. Epub 2020 Sep 9.

DOI:10.1007/s00423-020-01983-z
PMID:32902708
Abstract

PURPOSE

The role of sarcopenia in pathologic complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT) in non-metastatic locally advanced rectal cancer is currently unknown. The present study investigates the association between sarcopenia and post-nCRT pCR.

METHODS

The data of patients operated on following nCRT between January 2013 and January 2020 were collected retrospectively. Sarcopenia was diagnosed based on the calculation of the skeletal muscle index (SMI) from computed tomography carried out at the time of the initial diagnosis. A statistical analysis was then conducted for predictors of pCR.

RESULTS

The study included 61 patients with an average age of 57.3 years, 28 of whom formed the non-sarcopenic group (NSG) and 33 the sarcopenic group (SG). Of the patients, 32.7% were at clinical stage 2, and 67.3% were at clinical stage 3. Pathologic data following a mesorectal excision revealed a pCR rate of 21.4% in the NSG compared with 3% in the SG, which was a statistically significant difference (p = 0.025). The TNM downstaging rate was higher in the NSG than in the SG, although the difference was not statistically significant (50% vs. 33.3%, p = 0.28). A univariate analysis revealed the factors affecting pCR to be non-sarcopenia (p = 0.025), age < 61 years (p = 0.004), interval to surgery ≥ 8 weeks (p = 0.029), and serum CEA < 2.5 ng/ml (p = 0.035).

CONCLUSION

Sarcopenia was found to be a negative marker of pCR following nCRT in non-metastatic locally advanced rectal cancer.

摘要

目的

新辅助放化疗(nCRT)后非转移性局部晚期直肠癌病理完全缓解(pCR)中,肌肉减少症的作用尚不清楚。本研究探讨了肌肉减少症与 post-nCRT pCR 之间的关系。

方法

回顾性收集了 2013 年 1 月至 2020 年 1 月间 nCRT 后手术患者的数据。在初始诊断时通过计算计算机断层扫描(CT)得出的骨骼肌指数(SMI)来诊断肌肉减少症。然后对 pCR 的预测因素进行了统计学分析。

结果

研究纳入了 61 例平均年龄为 57.3 岁的患者,其中 28 例为非肌肉减少症组(NSG),33 例为肌肉减少症组(SG)。患者中,2型占 32.7%,3 型占 67.3%。直肠系膜切除术后的病理数据显示,NSG 的 pCR 率为 21.4%,而 SG 为 3%,差异有统计学意义(p = 0.025)。NSG 的 TNM 降级率高于 SG,但差异无统计学意义(50% vs. 33.3%,p = 0.28)。单因素分析显示,影响 pCR 的因素是非肌肉减少症(p = 0.025)、年龄<61 岁(p = 0.004)、手术间隔时间≥8 周(p = 0.029)和血清 CEA<2.5ng/ml(p = 0.035)。

结论

肌肉减少症是 nCRT 后非转移性局部晚期直肠癌 pCR 的阴性标志物。

相似文献

1
The impact of sarcopenia on pathologic complete response following neoadjuvant chemoradiation in rectal cancer.肌肉减少症对直肠癌新辅助放化疗后病理完全缓解的影响。
Langenbecks Arch Surg. 2020 Dec;405(8):1131-1138. doi: 10.1007/s00423-020-01983-z. Epub 2020 Sep 9.
2
[Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].局部晚期直肠癌患者新辅助治疗与全新辅助治疗的短期疗效及围手术期安全性比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):274-280. doi: 10.3760/cma.j.cn.441530-20190819-00312.
3
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
4
Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.肌肉减少症能否预测晚期直肠癌全新辅助治疗后的完全缓解?一项多中心观察性队列研究。
J Surg Oncol. 2023 Jul;128(1):75-84. doi: 10.1002/jso.27251. Epub 2023 Mar 27.
5
Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.新辅助放化疗治疗直肠癌后病理完全缓解的预测因素。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1607-1611. doi: 10.31557/APJCP.2021.22.5.1607.
6
[Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].[新辅助治疗后临床完全缓解的局部晚期直肠癌患者中观察等待策略与全直肠系膜切除术的长期疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):266-273. doi: 10.3760/cma.j.cn.441530-20200224-00081.
7
The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation.中性粒细胞与白蛋白比值作为直肠癌患者新辅助放化疗后病理完全缓解的预测指标。
Anticancer Drugs. 2016 Oct;27(9):879-83. doi: 10.1097/CAD.0000000000000411.
8
Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.新辅助放化疗后行肿瘤特异性直肠系膜切除术根治性切除固定性局部晚期直肠癌的肿瘤学结局:放疗后病理降期对局部复发和生存的影响。
Ann Surg. 2006 Dec;244(6):1024-30. doi: 10.1097/01.sla.0000225360.99257.73.
9
Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.使用氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描和血清癌胚抗原预测直肠癌新辅助放化疗后的肿瘤反应:一项前瞻性研究。
Abdom Radiol (NY). 2016 Aug;41(8):1448-55. doi: 10.1007/s00261-016-0698-7.
10
CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.CEA-预测直肠癌新辅助治疗后病理完全缓解的指标。
Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

引用本文的文献

1
A Scoping Review of the Implications and Applications of Body Composition Assessment in Locally Advanced and Locally Recurrent Rectal Cancer.局部进展期和局部复发性直肠癌身体成分评估的意义与应用范围综述
Cancers (Basel). 2025 Feb 28;17(5):846. doi: 10.3390/cancers17050846.
2
Impacts of sarcopenia on adverse events and prognosis in Chinese patients with esophageal cancer undergoing chemoradiotherapy.肌少症对接受放化疗的中国食管癌患者不良事件及预后的影响
Front Nutr. 2025 Feb 20;12:1523674. doi: 10.3389/fnut.2025.1523674. eCollection 2025.
3
Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer.
肌肉减少症对局部进展期直肠癌治疗结局和毒性的影响。
Medicina (Kaunas). 2024 Oct 1;60(10):1606. doi: 10.3390/medicina60101606.
4
Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.身体成分参数联合血液生物标志物及磁共振成像可预测局部晚期直肠癌新辅助放化疗的疗效。
Front Oncol. 2023 Nov 22;13:1242193. doi: 10.3389/fonc.2023.1242193. eCollection 2023.
5
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.局部晚期直肠癌新辅助放化疗后残留扁平黏膜病变患者病理完全缓解的预测因素
Chin J Cancer Res. 2022 Aug 30;34(4):383-394. doi: 10.21147/j.issn.1000-9604.2022.04.06.
6
Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer.肌肉减少症和肌脂肪变性在结直肠癌中的临床相关性
J Clin Med. 2022 May 6;11(9):2617. doi: 10.3390/jcm11092617.
7
Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy.肌肉减少症与放疗或放化疗后食管鳞癌患者的预后相关。
BMC Gastroenterol. 2022 Apr 30;22(1):211. doi: 10.1186/s12876-022-02296-9.